Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
PH94B Nasal Spray for Anxiety Induced by a Public Speaking ChallengeNCT04754802VTGNPhase 3Completed2022-06-22Actual
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)NCT04757610Opthea LimitedPhase 3Terminated2025-03-31Actual
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)NCT04757636Opthea LimitedPhase 3Terminated2025-03-31Actual
OCS-05 in Patients With Optic NeuritisNCT04762017OculisPhase 2Completed2024-09-16Actual
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069CNSPPhase 2Active not recruiting2026-04-27Estimated
PTG-300 in Patients With Polycythemia Vera and Elevated HematocritNCT04767802PTGXPhase 2Completed2023-03-15Actual
Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced MelanomaNCT04768881KPTIPhase 2Terminated2023-09-22Actual
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)NCT04768972IONSPhase 3Active not recruiting2026-06-17Actual
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)NCT04770753AGIOPhase 3Active not recruiting2023-11-13Actual
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)NCT04770779AGIOPhase 3Active not recruiting2024-04-11Actual
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNCT04773587ARQTPhase 3Completed2022-08-30Actual
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)NCT04773600ARQTPhase 3Completed2022-09-29Actual
Open-Label Extension Study of Trofinetide for Rett SyndromeNCT04776746ACADPhase 3Terminated2023-06-30Actual
A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionNCT04781647Assembly BiosciencesPhase 2Terminated2022-12-02Actual
Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04784091TARSPhase 3Completed2022-05-09Actual
Nomacopan (rVA576) in Transplant Associated Thrombotic MicroangiopathyNCT04784455AKARI TherapeuticsPhase 3Terminated2024-05-15Actual
Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.NCT04796324Allarity TherapeuticsPhase 2Terminated2024-12-01Actual
Assessing Clinical Outcomes in Alzheimer's Disease AgitationNCT04797715AXSMPhase 3Completed2022-11-21Actual
Evaluating the Effects of VQW-765 vs. Placebo in Performance AnxietyNCT04800237Vanda PharmaceuticalsPhase 2Completed2022-08-02Actual
A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis LipoidicaNCT04800562Processa PharmaceuticalsPhase 2Terminated2023-02-28Actual
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent SubjectsNCT04802837Summit TherapeuticsPhase 3Terminated2021-09-17Actual
Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNCT04804605ARQTPhase 3Completed2024-05-28Actual
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19NCT04805671IVVDPhase 2, Phase 3Terminated2022-02-10Actual
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial VitiligoNCT04811131ARQTPhase 2Terminated2021-08-09Actual
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction TherapyNCT04816526Cartesian TherapeuticsPhase 2Terminated2022-08-04Actual
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)NCT04816604Gossamer Bio USA, Inc.Phase 2Active not recruiting2027-12Estimated
A Study to Evaluate EDP 938 Regimens in Children With RSVNCT04816721ENTAPhase 2Completed2024-08-19Actual
BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid TumorsNCT04819373Eikon TherapeuticsPhase 2Completed2023-04-01Actual
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderNCT04819776Vanda PharmaceuticalsPhase 3Completed2022-09-07Actual
A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionNCT04820686Assembly BiosciencesPhase 2Terminated2023-03-30Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.